🇺🇸 FDA
Patent

US 7608632

Sulfonamide inhibitors of aspartyl protease

granted A61KA61K38/00A61P

Quick answer

US patent 7608632 (Sulfonamide inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61P, A61P31/12, A61P31/18